Diana Romero, Senior Editor of Nature Reviews Clinical Oncology, talking about the “Cancer at Nature Research” portal
Tell us a little about your role and background in this research area?
I am a biochemist by training, with 10 years postdoctoral experience in cancer research, and I have worked as an editor at Nature Reviews Clinical Oncology for 2 years. I see my career as a continuum, in the sense that first I was trying to answer single questions myself, and know I help disseminate the answers others have found. The question, which is complex and can be approached from many sides, is what causes cancer and how can we use that knowledge to treat patients?
What has been the most significant recent advances in Oncology research?
There have been many key advances at different levels. In terms of technology, many advances have been achieved because of the improvement in DNA sequencing. In clinical settings, these advances have resulted in the development of liquid biopsies. In terms of therapies, immunotherapies, in particular with CAR T cells, have received a lot of attention, but targeted therapies have also been important in the past decade.
What excites you most about the future of this research area?
What excites me most is that efforts are being made in several areas at the same time. Cancer researchers and clinicians are realising more and more about the importance of going outside their own comfort zone and collaborating.
Can you tell us more about the future developments of the Cancer at Nature Research portal? Are there plans for further enhancements to this product?
This is a very new project and, at the moment, what we want to see is whether the cancer researchers and oncologists community find it useful. We hope they do, and they make the portal their go-to place to keep up to date with cancer, and to submit their research.